CSPC Pharmaceutical Group Limited (CVG) — Cash Flow Quality Index
CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow Quality Index of 1.79x as of September 2020. Operating cash flow of €2.16 Billion exceeds net income of €1.20 Billion, indicating high earnings quality where cash backs reported profits. Explore CSPC Pharmaceutical Group Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC Pharmaceutical Group Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for CSPC Pharmaceutical Group Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of CSPC Pharmaceutical Group Limited to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year earnings quality comparison for CSPC Pharmaceutical Group Limited. For live market cap and the full company financial profile, see CVG stock market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €5.83 Billion | €3.88 Billion | ▲ +53.4% |
| 2024 | 0.98x | €4.53 Billion | €4.63 Billion | ▲ +49.5% |
| 2023 | 0.65x | €4.18 Billion | €6.38 Billion | ▼ -40.3% |
| 2022 | 1.10x | €7.63 Billion | €6.95 Billion | ▲ +63.4% |
| 2021 | 0.67x | €4.64 Billion | €6.90 Billion | ▼ -38.6% |
| 2020 | 1.09x | €6.74 Billion | €6.16 Billion | ▲ +7.4% |
| 2019 | 1.02x | €3.78 Billion | €3.71 Billion | ▼ -17.3% |
| 2018 | 1.23x | €3.80 Billion | €3.08 Billion | ▲ +3.8% |
| 2017 | 1.19x | €3.29 Billion | €2.77 Billion | ▼ -23.4% |
| 2016 | 1.55x | €2.92 Billion | €1.88 Billion | ▲ +14.8% |
| 2015 | 1.35x | €2.25 Billion | €1.67 Billion | ▼ -5.2% |
| 2014 | 1.42x | €1.81 Billion | €1.27 Billion | ▲ +70.0% |
| 2013 | 0.84x | €814.86 Million | €972.75 Million | — |